Hims & Hers announced it has acquired a U.S.-based peptide facility based in California. The company said the acquisition will enable the ...

“We’re aiming to have the cleanest, purest, highest-quality research peptides and bioregulators in the space,” says Campbell.

NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended ...

Pepticom, a pioneer in AI-driven peptide drug discovery and development, is collaborating on discovery projects with leading pharma and agriculture companies as well as developing its own in-house ...